Tag Archives: Eeva® System

Merck Serono’s strategic partner Auxogyn gets U.S. Food and Drug Administration clearance for Early Embryo Viability Assessment (Eeva®) System

FDA clearance validates Eeva System, which enables in-vitro fertilization (IVF) clinicians to offer the proprietary Eeva Test and further demonstrates commitment by Merck Serono and Auxogyn to bring innovative technologies to the IVF community Eeva Test first-of-a-kind prognostic, non-invasive test that provides IVF clinicians … Read the full press release